Tag: Prescription Drugs
ASA: Sustained Decrease Seen in Prescription Opioid Abuse in U.S.
Significant declines seen from 2002 to 2013 and 2014 and from 2015 to 2016, 2017, 2018
Atezolizumab Prolongs Survival in NSCLC With PD-L1 Expression
Overall survival longer than for chemotherapy in metastatic NSCLC with high PD-L1 expression
Gabapentin Does Not Lower Pain Scores in Chronic Pelvic Pain
Treatment also linked to more serious adverse events
Hydroxychloroquine Tied to Heart Problems Prior to Pandemic
Adverse outcomes include cardiomyopathy, QT prolongation, cardiac arrhythmias, heart failure
FDA Requiring Labeling Changes to Benzodiazepine Prescribing Information
Update to Boxed Warning must include risks for abuse, misuse, addiction, physical dependence, withdrawal reaction
Guidelines Updated for Managing Dyslipidemia to Cut CVD Risk
Moderate-dose statin therapy recommended for patients with 10-year CVD risk ≥12 percent
Major Adverse CV Event Risk Reduced With SGLT2 Inhibitors
Risks for MACE, MI, cardiovascular death, heart failure, all-cause mortality lower versus DPP-4 inhibitors
Metformin May Slow Cognitive Decline in Seniors With T2DM
Cognitive decline slower, dementia risk reduced in seniors with diabetes receiving metformin
PrEP Prescribing Low in the U.S., Even Among HIV Care Providers
About half of survey participants recruited from HIV CME courses reported ever prescribing PrEP
Avelumab Prolongs Survival in Advanced Urothelial Cancer
Findings seen in patients with advanced, metastatic disease that did not progress with first-line chemo
